Cardiology Perspective

 
 
  • March 16, 2018 This Week in Cardiology   ODYSSEY, VEST, mSTOPS, CANTOS, and the Black barbershop blood pressure study are among the presentations from the 2018 American College of Cardiology meeting reviewed in this week's podcast.
  • ACC 2018Sanjay Kaul Grades Four Big Trials From ACC 2018 Dr Kaul rates trials on alirocumab, black barbershop-based healthcare, canakinumab, and the wearable cardioverter defibrillator, from the 2018 American College of Cardiology Scientific Sessions.
  • The Future of Medicine From a Leader in Biosensors   Dr Eric Topol talks with pioneering researcher John Rogers about how his flexible electronic devices are being used in medicine and what further developments lie ahead.
  • ECG Challenge: What Is This Post-Stenting Rhythm? After myocardial infarction and stenting, what does this man's ECG show?
  • Pharmacists and Barbers on the Cutting Edge of Medicine Dr Mandrola's hands-down favorite study from the 2018 American College of Cardiology meeting showed that a pharmacist-led intervention in black-owned barbershops cut hypertension in black men.
  • Will Physicians Ever Adopt Obesity Drugs? A new Medscape survey shows that prescribers are still skeptical about FDA-approved medications to help obese patients lose weight.
  • More Positives for PCSK9 inhibitors and the LDL-C Hypothesis   The co-investigator for the ODYSSEY study of alirocumab discusses which patients will benefit most from the expensive biologic and why the mortality reduction finding comes with qualifiers.
  • ACC 2018 MOMENTUM-3: The Future of the LVAD Is Here and Now A trial showing better outcomes for HeartMate 3 over HeartMate II sends Dr Walton-Shirley down memory lane to recall the patients she has referred for implantation of a left ventricular assist device (LVAD).
  • ACC 2018Another Way to Save a Life: the MANAGE Trial Dr Walton-Shirley was impressed by a study on dabigatran for myocardial injury after noncardiac surgery at the American College of Cardiology Annual Scientific Session.
  • Statins in the Elderly: Evidence-Based or Not? What does the evidence show, and is it enough to guide decisions about statins for older adults?
  • ACC 2018Ten Quick Thoughts on ODYSSEY Despite a suggested mortality benefit for the PCSK9 inhibitor alirocumab, in high-risk ACS patients, a return to lipid targets may be the cost-effective lesson from this trial, argues Dr Mandrola.
  • ACC 2018How Want Became Need With ODYSSEY Dr Walton-Shirley would like to prescribe more PCSK9 inhibitors, given positive data from the American College of Cardiology meeting, but the prior authorization process may break her first.
  • ACC 2018The VEST Trial Failed, and So Did the Press Release The first randomized trial on the wearable cardioverter defibrillator didn't meet its primary endpoint, yet the press release was overly positive.
  • Mar 9, 2018 This Week in Cardiology   Obesity in young people, type-2 diabetes, the risks of varicose veins, on-pump vs off-pump coronary artery bypass surgery and an ACC preview are the topics discussed in this week's podcast.
  • What Did Cardiologists Learn Recently That PCPs Should Know? What are the five articles that cardiologists read in the last 12 months that may change primary care management of patients with cardiovascular disease?
  • How to Assess and Manage Stroke Risk in Atrial Fibrillation?   Drs Acharya, Friedman, and Klaas discuss when to anticoagulate patients with atrial fibrillation; additional factors that contribute to stroke risk; and treatment options for stroke prevention.
  • The Slam Dunk NSTEMI That Was Almost an Epic Fail Using a basketball analogy, Dr Walton-Shirley describes a case that bounced around a number of healthcare professionals who almost 'dropped the ball.'
  • The State of the Art in Cardiovascular Risk Reduction Dr Williams provides an overview of the latest information on cardiovascular risk reduction, from the American College of Cardiology.
  • Mandrola Previews 2018 ACC PCSK9 inhibitors, LifeVest, and his-bundle pacing are among Dr Mandrola's picks for what to look for at the 2018 American College of Cardiology Scientific Sessions.
  • March 2, 2018 This Week in Cardiology   Vegetarian vs Mediterranean diets, a clarithromycin alert, a new stent, best choice of IV fluid, and early work in prevention Type I diabetes are discussed in this week's podcast.